Wellington Management Group’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-779,559
| Closed | -$138M | – | 2049 |
|
|
2020
Q1 | $138M | Sell |
779,559
-57,275
| -7% | -$10.8M | 0.04% | 390 |
|
|
2019
Q4 | $160M | Sell |
836,834
-872,202
| -51% | -$157M | 0.03% | 456 |
|
|
2019
Q3 | $288M | Sell |
1,709,036
-21,083,760
| -93% | -$3.43B | 0.06% | 288 |
|
|
2019
Q2 | $3.82B | Sell |
22,792,796
-1,859,004
| -8% | -$257M | 0.84% | 20 |
|
|
2019
Q1 | $3.61B | Sell |
24,651,800
-282,159
| -1% | -$40.9M | 0.82% | 23 |
|
|
2018
Q4 | $3.33B | Buy |
24,933,959
+2,480,031
| +11% | +$407M | 0.83% | 20 |
|
|
2018
Q3 | $4.28B | Buy |
22,453,928
+461,570
| +2% | +$84.8M | 0.9% | 14 |
|
|
2018
Q2 | $3.67B | Buy |
21,992,358
+319,806
| +1% | +$51.3M | 0.82% | 18 |
|
|
2018
Q1 | $3.65B | Buy |
21,672,552
+177,672
| +0.8% | +$29.8M | 0.83% | 17 |
|
|
2017
Q4 | $3.52B | Buy |
21,494,880
+1,877,004
| +10% | +$337M | 0.78% | 20 |
|
|
2017
Q3 | $4.02B | Sell |
19,617,876
-1,086,961
| -5% | -$253M | 0.92% | 13 |
|
|
2017
Q2 | $5.03B | Sell |
20,704,837
-851,105
| -4% | -$200M | 1.19% | 8 |
|
|
2017
Q1 | $5.15B | Sell |
21,555,942
-1,130,455
| -5% | -$263M | 1.24% | 9 |
|
|
2016
Q4 | $4.76B | Sell |
22,686,397
-1,469,528
| -6% | -$304M | 1.2% | 9 |
|
|
2016
Q3 | $5.56B | Buy |
24,155,925
+273,953
| +1% | +$66.9M | 1.39% | 6 |
|
|
2016
Q2 | $5.52B | Buy |
23,881,972
+3,110,863
| +15% | +$717M | 1.43% | 7 |
|
|
2016
Q1 | $5.57B | Sell |
20,771,109
-503,620
| -2% | -$144M | 1.47% | 6 |
|
|
2015
Q4 | $6.65B | Buy |
21,274,729
+3,396,092
| +19% | +$1.01B | 1.74% | 5 |
|
|
2015
Q3 | $4.86B | Buy |
17,878,637
+587,613
| +3% | +$180M | 1.35% | 7 |
|
|
2015
Q2 | $5.25B | Sell |
17,291,024
-678,457
| -4% | -$202M | 1.35% | 7 |
|
|
2015
Q1 | $5.35B | Buy |
17,969,481
+2,190,873
| +14% | +$625M | 1.38% | 7 |
|
|
2014
Q4 | $4.06B | Buy |
15,778,608
+811,223
| +5% | +$203M | 1.07% | 13 |
|
|
2014
Q3 | $3.61B | Buy |
14,967,385
+6,495,508
| +77% | +$1.45B | 1% | 15 |
|
|
2014
Q2 | $1.89B | Buy |
8,471,877
+718,957
| +9% | +$149M | 0.51% | 41 |
|
|
2014
Q1 | $1.6B | Buy |
7,752,920
+2,264,246
| +41% | +$448M | 0.44% | 50 |
|
|
2013
Q4 | $922M | Buy |
5,488,674
+850,086
| +18% | +$133M | 0.27% | 86 |
|
|
2013
Q3 | $668M | Buy |
4,638,588
+188,562
| +4% | +$25.1M | 0.21% | 106 |
|
|
2013
Q2 | $562M | Buy |
+4,450,026
| New | +$504M | 0.18% | 114 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Wellington Management Group's AGN Position: Q2 2020 in Review
Wellington Management Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 779,559 shares — an estimated $138M sold.
Wellington Management Group first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $6.65B in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Wellington Management Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Wellington Management Group sold 779,559 Allergan plc shares in Q2 2020, an estimated $138M.
- Wellington Management Group first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
- Wellington Management Group's Allergan plc position peaked at $6.65B in Q4 2015.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Wellington Management Group's 13F filing for Q2 2020, filed 14 Aug 2020.